From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver Pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and business process infrastructure for market access and therapy commercialization.
Solutions overview
IntegriChain delivers pharma’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, managed services and expert advisors to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
IntegriChain provides wide array of resources to help you navigate your journey to market access success.
Resources overview
We help all stakeholders in the pharmaceutical industry drive access. We do this through our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts and pricing, gross-to-net, channel, and patient services – unlocking strategic payer, provider, pharmacy and patient access insights for our life sciences customers.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, Market Access experts, analysts, technologies, and advisory professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Pharmaceutical manufacturers have few existing measures of the inventory held in retail stores, distribution centers, and third-party returns processors. IntegriChain Inventory Analytics reports 100% of inventory in the retail channel, even in pharmacy stores and distribution centers that do not report their inventories.
Our Inventory Analytics provides the industry’s only comprehensive reporting and management of inventory in the downstream retail channel. Widely accepted and validated by the audit community and leading finance teams, Inventory Analytics empowers teams throughout your organization to align around a shared and accurate view into total pipeline inventory.
Based on actual sell-in, returns, and point-of-sale data, pharmaceutical Inventory Analytics gives you a weekly report of retail inventories on hand at an individual SKU level. Inventory Analytics captures 100% of the inventory located in chain distribution centers, chain stores, independent stores, and third-party morgues that house product not yet returned to the manufacturer or wholesaler.
Tie returns reserves to an accurate and up-to-date measurement of total retail inventory.
Quantify how retail channel inventories impacted corporate sales results in the preceding quarter, improving investor clarity on the true direction of demand.
Incorporate retail inventories into order forecast models; improving the net accuracy of weekly order management and quarter/year-end sales forecasting
Clarify how projection errors in syndicated data are causing disconnects between reported Rx demand and factory sales; develop factors to adjust Rx demand and improve demand forecast accuracy.
Provide supply chain partners more accurate forecasts by SKU, improving overall product availability and allowing tighter pharmaceutical inventory management.
<span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span>
